Cabergoline (Dopamine Agonist)

DRUG2 trials

Sponsors

University Hospital, Basel, Switzerland, Zealand University Hospital

Conditions

ProlactinomaScizophrenia

Phase 4

Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment

RecruitingNCT07045935

University Hospital, Basel, SwitzerlandProlactinoma

Start: 2025-09-16End: 2029-12-31Target: 60Updated: 2025-09-23

Carbergoline for Antipsychotic Induced Hyperprolactinemia.

Not yet recruitingNCT07386080

Zealand University HospitalScizophrenia

Start: 2026-05-01End: 2029-05-01Target: 146Updated: 2026-02-04